Literature DB >> 15289348

Differential activation of the phosphatidylinositol 3'-kinase/Akt survival pathway by ionizing radiation in tumor and primary endothelial cells.

Daniel Zingg1, Oliver Riesterer, Doriano Fabbro, Christoph Glanzmann, Stephan Bodis, Martin Pruschy.   

Abstract

Ionizing radiation induces an intracellular stress response via activation of the phosphatidylinositol 3'-kinase (PI3K)/Akt survival pathway. In tumor cells, the PI3K/Akt pathway is induced through activation of members of ErbB receptor tyrosine kinases. Here, we investigated the receptor dependence of radiation-induced PI3K/Akt activation in tumor cells and in endothelial cells. The integrity of both the ErbB and the vascular endothelial growth factor (VEGF) ligand-activated PI3K/Akt pathway in endothelial cells was demonstrated using specific ErbB and VEGF receptor tyrosine kinase inhibitors. Irradiation of endothelial cells resulted in protein kinase B (PKB)/Akt activation in a similar time course as observed in response to VEGF. More importantly, radiation-induced PKB/Akt phosphorylation in endothelial cells was strongly down-regulated by the VEGF receptor tyrosine kinase inhibitor, whereas the ErbB receptor tyrosine kinase inhibitor did not affect PKB/Akt stimulation in response to irradiation. An opposite receptor dependence for radiation-induced PKB/Akt phosphorylation was observed in ErbB receptor-overexpressing A431 tumor cells. Furthermore, direct VEGF receptor phosphorylation was detected after irradiation in endothelial cells in absence of VEGF, which was almost completely inhibited after irradiation in presence of the VEGF receptor tyrosine kinase inhibitor. These data demonstrate that ionizing radiation induces VEGF ligand-independent but VEGF receptor-dependent PKB/Akt activation in endothelial cells and that PI3K/Akt pathway activation by radiation occurs in a differential cell type and receptor-dependent pattern.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15289348     DOI: 10.1158/0008-5472.CAN-03-3369

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  Sensitivity control through attenuation of signal transfer efficiency by negative regulation of cellular signalling.

Authors:  Yu Toyoshima; Hiroaki Kakuda; Kazuhiro A Fujita; Shinsuke Uda; Shinya Kuroda
Journal:  Nat Commun       Date:  2012-03-13       Impact factor: 14.919

2.  Integrin α6β4-Src-AKT signaling induces cellular senescence by counteracting apoptosis in irradiated tumor cells and tissues.

Authors:  Seung Hee Jung; Minyoung Lee; Hyun A Park; Hyung Chul Lee; Donghee Kang; Hyun Jung Hwang; Chanho Park; Dong-Min Yu; Yu Ri Jung; Mi-Na Hong; Yong-Nyun Kim; Heon Joo Park; Young-Gyu Ko; Jae-Seon Lee
Journal:  Cell Death Differ       Date:  2018-05-21       Impact factor: 15.828

Review 3.  Multimodality treatment of brain metastases from renal cell carcinoma in the era of targeted therapy.

Authors:  Bassanelli Maria; Viterbo Antonella; Roberto Michela; Giacinti Silvana; Staddon Anita; Aschelter Anna Maria; D'Antonio Chiara; Marchetti Paolo
Journal:  Ther Adv Med Oncol       Date:  2016-07-25       Impact factor: 8.168

4.  Beta1 integrin inhibition dramatically enhances radiotherapy efficacy in human breast cancer xenografts.

Authors:  Catherine C Park; Hui J Zhang; Evelyn S Yao; Chong J Park; Mina J Bissell
Journal:  Cancer Res       Date:  2008-06-01       Impact factor: 12.701

5.  Radiation-induced CXCL16 release by breast cancer cells attracts effector T cells.

Authors:  Satoko Matsumura; Baomei Wang; Noriko Kawashima; Steve Braunstein; Michelle Badura; Thomas O Cameron; James S Babb; Robert J Schneider; Silvia C Formenti; Michael L Dustin; Sandra Demaria
Journal:  J Immunol       Date:  2008-09-01       Impact factor: 5.422

6.  Cytosolic phospholipase A2: targeting cancer through the tumor vasculature.

Authors:  Amanda Linkous; Ling Geng; Andrej Lyshchik; Dennis E Hallahan; Eugenia M Yazlovitskaya
Journal:  Clin Cancer Res       Date:  2009-02-24       Impact factor: 12.531

7.  Adaptive radiosurgery based on two simultaneous dose prescriptions in the management of large renal cell carcinoma brain metastases in critical areas: Towards customization.

Authors:  Georges Sinclair; M Stenman; H Benmakhlouf; P Johnstone; P Wersäll; M Lindskog; M A Hatiboglu; U Harmenberg
Journal:  Surg Neurol Int       Date:  2020-02-14

8.  Gamma Tocotrienol Protects Mice From Targeted Thoracic Radiation Injury.

Authors:  Vidya P Kumar; Sasha Stone; Shukla Biswas; Neel Sharma; Sanchita P Ghosh
Journal:  Front Pharmacol       Date:  2020-11-12       Impact factor: 5.810

9.  Radiation-Induced Gene Expression Changes in High and Low Grade Breast Cancer Cell Types.

Authors:  Valentina Bravatà; Claudia Cava; Luigi Minafra; Francesco Paolo Cammarata; Giorgio Russo; Maria Carla Gilardi; Isabella Castiglioni; Giusi Irma Forte
Journal:  Int J Mol Sci       Date:  2018-04-04       Impact factor: 5.923

10.  Ginsenoside-Rp1 inhibits radiation-induced effects in lipopolysaccharide-stimulated J774A.1 macrophages and suppresses phenotypic variation in CT26 colon cancer cells.

Authors:  Ji Sue Baik; You Na Seo; Joo Mi Yi; Man Hee Rhee; Moon-Taek Park; Sung Dae Kim
Journal:  J Ginseng Res       Date:  2020-01-31       Impact factor: 6.060

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.